Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Operating Leases (2022 - 2025)

Historic Operating Leases for Regenerative Medical Technology (RMTG) over the last 4 years, with Q3 2025 value amounting to $543788.0.

  • Regenerative Medical Technology's Operating Leases rose 355129.93% to $543788.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $543788.0, marking a year-over-year increase of 355129.93%. This contributed to the annual value of $211716.0 for FY2024, which is 770088.43% up from last year.
  • Regenerative Medical Technology's Operating Leases amounted to $543788.0 in Q3 2025, which was up 355129.93% from $273461.0 recorded in Q2 2025.
  • In the past 5 years, Regenerative Medical Technology's Operating Leases ranged from a high of $543788.0 in Q3 2025 and a low of $1395.0 during Q4 2022
  • Its 4-year average for Operating Leases is $136353.3, with a median of $52294.0 in 2022.
  • As far as peak fluctuations go, Regenerative Medical Technology's Operating Leases skyrocketed by 9455.2% in 2023, and later surged by 770088.43% in 2024.
  • Quarter analysis of 4 years shows Regenerative Medical Technology's Operating Leases stood at $1395.0 in 2022, then surged by 94.55% to $2714.0 in 2023, then surged by 7700.88% to $211716.0 in 2024, then surged by 156.85% to $543788.0 in 2025.
  • Its Operating Leases was $543788.0 in Q3 2025, compared to $273461.0 in Q2 2025 and $285206.0 in Q1 2025.